Neuropeptide Y (2-36) (porcine) lacks the N-terminal tyrosine and C-terminal residue, generating a variant with altered receptor bias. Its sequence supports analyses of Y2-preferring activity in porcine systems. Researchers employ it to study presynaptic modulation and feedback regulation. The peptide aids exploration of subtype-selective NPY signaling.
CAT No: N05012
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More